Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NovoCure Ltd Director's Dealing 2015

Oct 9, 2015

31949_dirs_2015-10-09_9cd40636-3b84-43f3-9c5b-6589d296639a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2015-10-07

Reporting Person: Wyss Hansjoerg (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-10-07 Ordinary Shares C 9954748 Acquired 9954748 Direct
2015-10-07 Ordinary Shares C 825649 Acquired 10780397 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-10-07 Series I Convertible Preferred Shares $ C 9954748 Disposed Ordinary Shares (9954748) Direct
2015-10-07 Series I Convertible Preferred Shares $ C 825649 Disposed Ordinary Shares (825649) Indirect

Footnotes

F1: Mr. Wyss possesses no voting or investment power over shares held by The Hansjoerg Wyss 2004 Descendants Trust.

F2: N/A.

F3: Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series automatically converted into ordinary shares upon consummation of the issuer's initial public offering on October 7, 2015.